Financials in USD. Standardized financial statements.
A compact view of how PureTech Health plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.76M | $4.32M | $750,000 | $2.09M | $9.98M | $8.34M | $8.69M | $16.37M | $650,000 | $4.43M |
| Revenue Growth? | +10.4% | +475.3% | -64.1% | -79.1% | +19.6% | -4.0% | -46.9% | +2418.6% | -85.3% | 0.0% |
| Cost of Revenue? | $3.42M | $0 | $2.39M | $152.43M | $110.47M | $0 | $85.85M | $77.40M | $71.03M | $1.44M |
| Gross Profit? | $1.34M | $4.32M | -$1.64M | -$150.34M | -$100.49M | $8.34M | -$77.16M | -$61.03M | -$70.39M | $2.99M |
| Gross Margin? | +28.1% | +100.0% | -218.9% | -7193.4% | -1007.0% | +100.0% | -888.1% | -372.8% | -10828.5% | +67.6% |
| Operating Expenses? | $102.06M | $140.41M | $146.95M | $199.90M | $160.26M | $127.87M | $144.09M | $120.39M | $116.07M | $78.36M |
| Operating Income? | -$100.72M | -$136.09M | -$146.20M | -$197.81M | -$150.28M | -$119.53M | -$135.40M | -$104.02M | -$115.42M | -$73.93M |
| EBITDA? | -$97.29M | $37.38M | -$11.91M | -$51.24M | $26.25M | -$144.76M | $476.06M | -$37.60M | -$42.85M | -$77.39M |
| Income Before Tax | -$113.39M | $23.77M | -$36.10M | -$92.78M | -$58.95M | $18.97M | $478.47M | -$68.44M | -$70.71M | -$83.18M |
| Income Tax Expense | -$860,725 | -$4.01M | $30.52M | -$55.72M | $3.76M | $14.40M | $112.41M | $2.22M | -$14,000 | -$1.57M |
| Net Income? | -$112.18M | $53.51M | -$65.70M | -$50.35M | -$60.56M | $5.99M | $421.14M | -$43.65M | $26.47M | -$48.79M |
| EPS? | $-0.47 | $0.20 | $-0.24 | $-0.18 | $-0.21 | $0.02 | $1.54 | $-0.16 | $0.13 | $-0.21 |
| Diluted EPS? | $-0.47 | $0.20 | $-0.24 | $-0.18 | $-0.21 | $0.02 | $1.50 | $-0.16 | $0.13 | $-0.21 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality